Literature DB >> 36149530

Long-term use of broad-spectrum antibiotics affects Ly6Chi monocyte recruitment and IL-17A and IL-22 production through the gut microbiota in tumor-bearing mice treated with chemotherapy.

Yanhong Wu1, Xiaolei Tang2, Feng Hu3, Tao Zhu1, Hui Liu1, Yanjing Xiong1, Xiaoxuan Zuo1, Aiping Xu4, Xiufen Zhuang5.   

Abstract

The protective effects of antibiotics against infection in cancer patients treated with chemotherapy remains unclear and related studies have been performed in healthy or pathogen-infected animal models. Here, we aimed to study the effects of antibiotic use on intestinal infection in tumor-bearing mice treated with chemotherapy and to determine the underlying mechanisms. Subcutaneous CT26 tumor-bearing mice were assigned to four groups: the control (Ctrl) group without any treatment, the antibiotic (ATB) group treated with a mixture of ampicillin, streptomycin, and colistin, the 5-fluorouracil (FU) group treated with four cycles of intraperitoneal injections of FU, and the ATB + FU group treated with the combination of ATB and FU. Gut microbial composition was determined and mesenteric lymph nodes (mLNs) were isolated for bacterial culturing. Intestinal permeability and integrity were assessed and the expression of cytokines was analyzed by quantitative PCR, ELISA, or flow cytometry (FCM). Monocytes in the colonic lamina propria (LP) were measured by FCM. Compared with the Ctrl and FU groups, the numbers of positive bacterial culturing results for mLNs were higher, and gut bacterial compositions were altered in the ATB and ATB + FU groups, with significantly decreased alpha diversity in the ATB + FU group. Intestinal integrity regarding the expression of tight junction proteins and intestinal permeability were not impaired significantly after treatments, but the colons were shorter in the ATB + FU group. The expression levels of intestinal IL-17A and IL-22, as well as the percentages of IL-17A+ cells in the colonic LP of the ATB + FU group, were lower than those in the FU group. The percentages of Ly6Chi monocytes in the colonic LP were lower, but those in the spleen were higher in the ATB + FU group than in the FU group. The mRNA levels of colonic CCL8 were reduced in the ATB + FU group. Antibiotic use is associated with an increased incidence of intestinal infections in tumor-bearing mice treated with chemotherapy, which might in turn be associated with a dysregulated gut microbiota that inhibits colonic monocyte recruitment and IL-17A and IL-22 production.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antibiotic; Gut microbiota; IL-17A; IL-22; Monocyte

Year:  2022        PMID: 36149530     DOI: 10.1007/s12026-022-09313-9

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  66 in total

1.  Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.

Authors:  M L Sulis; T M Blonquist; K E Stevenson; S K Hunt; S Kay-Green; U H Athale; L A Clavell; P D Cole; K M Kelly; C Laverdiere; J M Leclerc; B Michon; M A Schorin; J G Welch; D S Neuberg; S E Sallan; L B Silverman
Journal:  Pediatr Blood Cancer       Date:  2018-01-10       Impact factor: 3.167

2.  2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

Authors:  M S Aapro; J Bohlius; D A Cameron; Lissandra Dal Lago; J Peter Donnelly; N Kearney; G H Lyman; R Pettengell; V C Tjan-Heijnen; J Walewski; Damien C Weber; C Zielinski
Journal:  Eur J Cancer       Date:  2010-11-20       Impact factor: 9.162

3.  Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease.

Authors:  James D Lewis; Eric Z Chen; Robert N Baldassano; Anthony R Otley; Anne M Griffiths; Dale Lee; Kyle Bittinger; Aubrey Bailey; Elliot S Friedman; Christian Hoffmann; Lindsey Albenberg; Rohini Sinha; Charlene Compher; Erin Gilroy; Lisa Nessel; Amy Grant; Christel Chehoud; Hongzhe Li; Gary D Wu; Frederic D Bushman
Journal:  Cell Host Microbe       Date:  2015-10-14       Impact factor: 21.023

Review 4.  Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.

Authors:  Ofrat Beyar-Katz; Yaakov Dickstein; Sara Borok; Liat Vidal; Leonard Leibovici; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2017-06-03

5.  Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis.

Authors:  R Dessein; M Gironella; C Vignal; L Peyrin-Biroulet; H Sokol; T Secher; S Lacas-Gervais; J-J Gratadoux; F Lafont; J-C Dagorn; B Ryffel; S Akira; P Langella; G Nùñez; J-C Sirard; J Iovanna; M Simonet; M Chamaillard
Journal:  Gut       Date:  2009-01-27       Impact factor: 23.059

6.  Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia.

Authors:  Susanna Felsenstein; Etan Orgel; Teresa Rushing; Cecilia Fu; Jill A Hoffman
Journal:  Pediatr Infect Dis J       Date:  2015-04       Impact factor: 2.129

7.  Risk of infection among patients with non-metastatic solid tumors or non-Hodgkin's lymphoma receiving myelosuppressive chemotherapy and antimicrobial prophylaxis in US clinical practice.

Authors:  Derek Weycker; David Chandler; Rich Barron; Hairong Xu; Hongsheng Wu; John Edelsberg; Gary H Lyman
Journal:  J Oncol Pharm Pract       Date:  2016-07-09       Impact factor: 1.809

Review 8.  Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.

Authors:  Nicole M Kuderer; David C Dale; Jeffrey Crawford; Gary H Lyman
Journal:  J Clin Oncol       Date:  2007-07-20       Impact factor: 44.544

9.  Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study.

Authors:  Eva Culakova; Ramya Thota; Marek S Poniewierski; Nicole M Kuderer; Adane F Wogu; David C Dale; Jeffrey Crawford; Gary H Lyman
Journal:  Cancer Med       Date:  2014-02-17       Impact factor: 4.452

Review 10.  Enlisting commensal microbes to resist antibiotic-resistant pathogens.

Authors:  James W Keith; Eric G Pamer
Journal:  J Exp Med       Date:  2018-10-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.